Endometrial morphologic response to hormonal environment.
D000230:Adenocarcinoma / Q000473:pathology; D000328:Adult; D000368:Aged; D002278:Carcinoma in Situ / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D004717:Endometrium / Q000187:drug effects / Q000473:pathology*; D004848:Epithelium / Q000648:ultrastructure; D004958:Estradiol / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000188:drug therapy; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008855:Microscopy, Electron, Scanning; D008875:Middle Aged; D008928:Mitochondria / Q000648:ultrastructure; D009092:Mucous Membrane / Q000648:ultrastructure; D010060:Ovulation / Q000187:drug effects; D045167:Progesterone Congeners / Q000627:therapeutic use; D012270:Ribosomes / Q000648:ultrastructure; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000473:pathology
D004967:Estrogens; D045167:Progesterone Congeners; D004958:Estradiol; D008525:Medroxyprogesterone